| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7,9 M € | +0.4% | 7,8 M € | -5.3% | 8,3 M € | -2.0% | 8,5 M € | -24.3% | 11,2 M € | -7.1% | 12,0 M € | -17.3% | 14,5 M € | +7.9% | 13,5 M € | +34.2% | 10,0 M € | +51.6% | 6,6 M € | +5.9% | 6,3 M € | -6.4% | 6,7 M € | +17.9% | 5,7 M € | -1.1% | 5,7 M € | +6.3% | 5,4 M € | +8.2% | 5,0 M € | +40.4% | 3,5 M € | |
| EBITDA | 888,8 k € | +7.9% | 823,5 k € | -20.8% | 1,0 M € | -79.1% | 5,0 M € | +126.0% | 2,2 M € | +63.3% | 1,3 M € | -9.6% | 1,5 M € | -11.8% | 1,7 M € | +375.1% | 356,4 k € | -34.0% | 540,2 k € | +53.2% | 352,5 k € | -35.5% | 546,1 k € | -1.0% | 551,5 k € | -12.7% | 631,9 k € | +65.8% | 381,1 k € | -50.7% | 773,2 k € | +102.8% | 381,2 k € | |
| Operating profit | 429,6 k € | +6.7% | 402,4 k € | -15.8% | 477,9 k € | -89.1% | 4,4 M € | +200.6% | 1,5 M € | +314.9% | 352,6 k € | -53.2% | 752,7 k € | +9.7% | 686,3 k € | +284.6% | 178,5 k € | -52.6% | 376,4 k € | +174.1% | 137,3 k € | -64.7% | 389,0 k € | -1.6% | 395,5 k € | +13.4% | 348,8 k € | +172.2% | 128,2 k € | -75.5% | 522,3 k € | +108.9% | 250,0 k € | |
| Profit/loss | 471,2 k € | +27.4% | 370,0 k € | +21.5% | 304,4 k € | -89.7% | 2,9 M € | +314.9% | 710,5 k € | +1416.4% | -54,0 k € | -113.6% | 397,1 k € | +25.6% | 316,1 k € | +2591.8% | -12,7 k € | -105.8% | 217,0 k € | +297.9% | 54,5 k € | -74.0% | 209,7 k € | -14.4% | 245,1 k € | +6.7% | 229,7 k € | +171.6% | 84,6 k € | -75.8% | 349,2 k € | +120.9% | 158,1 k € | |
| Equity | 8,5 M € | +5.9% | 8,0 M € | +4.8% | 7,7 M € | +4.1% | 7,4 M € | +66.6% | 4,4 M € | +19.1% | 3,7 M € | -1.4% | 3,8 M € | +11.8% | 3,4 M € | +34.7% | 2,5 M € | +0.8% | 2,5 M € | +13.0% | 2,2 M € | +2.5% | 2,1 M € | +10.9% | 1,9 M € | +14.5% | 1,7 M € | +15.8% | 1,5 M € | +6.2% | 1,4 M € | +34.1% | 1,0 M € | |
| Total assets | 9,7 M € | +8.5% | 9,0 M € | -9.6% | 9,9 M € | -49.9% | 19,8 M € | -9.5% | 21,9 M € | +3.8% | 21,1 M € | +83.3% | 11,5 M € | +30.3% | 8,9 M € | +32.8% | 6,7 M € | +30.4% | 5,1 M € | +52.9% | 3,3 M € | -13.4% | 3,9 M € | +7.1% | 3,6 M € | -20.6% | 4,5 M € | +6.2% | 4,3 M € | -20.1% | 5,4 M € | +52.8% | 3,5 M € | |
| Cash | 6,0 M € | +56.1% | 3,9 M € | +19049.5% | 20,1 k € | — | 47,2 € | +0.9% | 46,8 € | -71.9% | 166,3 € | — | — | — | — | — | — | 517,7 k € | +0.1% | 517,2 k € | +2.6% | 504,1 k € | +23.0% | 409,7 k € | ||||||||||
| Debts | 1,0 M € | +35.1% | 745,8 k € | -63.2% | 2,0 M € | -83.4% | 12,2 M € | -29.4% | 17,3 M € | +0.6% | 17,2 M € | +131.9% | 7,4 M € | +45.4% | 5,1 M € | +27.6% | 4,0 M € | +54.6% | 2,6 M € | +143.6% | 1,1 M € | -34.9% | 1,6 M € | +3.2% | 1,6 M € | -43.8% | 2,8 M € | +3.5% | 2,7 M € | -31.3% | 4,0 M € | +63.7% | 2,4 M € | |
| Staff | 17,1 | 16,5 | 17,5 | 19,8 | 25 | 23,1 | 27,8 | 29,4 | 24,3 | 22,4 | 14,9 | 15,4 | 12,5 | 11,8 | 10,1 | 10 | 9,9 | |||||||||||||||||
Public limited company · Gent · incorporated on 28/01/2000 · 17,1 ETP
Public limited company profitable and well capitalised. Cash position rising (+56.1%).
Solid counterparty for a standard engagement.
INTEGRA LS (BENELUX) is a Public limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 17,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette